Crescent Ventures Leads $10M Round for CrossBridge Bio

CE-Ventures, the venture capital arm of UAE-based Crescent Enterprises, and TMC Venture Fund have co-led a $10 million funding round for CrossBridge Bio, a Houston-based biotech firm, with participation from Portal Innovations, Alexandria Ventures, and Linden Lake Labs.

More to Know:

  • CrossBridge Bio was founded in 2023 by Michael Jason Torres.
  • The startup focuses on developing therapeutics, particularly for solid tumours.

 

 

 

 

 

مقالات ذات صلة

UAE-based Klaim has raised $10 million in a Series A round led...

Startup: FinTech. Founding date: 2021. Country: UAE. Investors: MEVP, Wa’ed Ventures, Mubadala...

Parties: Public Investment Fund (PIF), Neo Space Group (NSG). Event: Launch. Location:...